Skip to content
Research Article Open access CC BY 4.0

Management of Metastatic Colorectal Cancer : A Case Series of 20 Patients

Elwassi Anas, Belbsir Mohamed, Kenza Benjelloun Touimi, Hajri Amal, Erguibi Driss, Boufettal Rachid, Rifki Jai Saad, Chehab Farid

Asian Journal of Research in Surgery · pp. 215–218 · Published 31 May 2025

10.9734/ajrs/2025/v8i1286

Abstract

Metastatic colorectal cancer (mCRC) represents a major public health challenge, characterized by high morbidity and mortality. This retrospective study, conducted at Ibn Rochd University Hospital in Casablanca from 2019 to 2023, analyzes the epidemiological, clinical, and therapeutic characteristics of 20 patients diagnosed with mCRC. The mean age was 56 years, with a male predominance. The liver was the most common metastatic site. Management relied on a multidisciplinary approach combining surgery, chemotherapy, and, in selected cases, radiotherapy. The FOLFOX regimen was the most frequently administered. The resectability rate of liver metastases was 40%. Median overall survival was 12.6 months. Recent advances, such as personalized medicine and liver transplantation, offer new opportunities for improving survival and quality of life in these patients.

Metastatic colorectal cancer therapeutic advancements Colorectal Cancer metastases

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.